Daymark Wealth Partners’s GSK GSK Stock Holding History

Daymark Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$460K	Sell	8,783 -268	-3%	-$14.2K	0.01%	512
2026 Q1	$500K	Buy	9,051 +969	+12%	+$52.5K	0.02%	424
2025 Q4	$396K	Buy	8,082 +1,312	+19%	+$61.2K	0.01%	443
2025 Q3	$292K	Buy	6,770 +1,044	+18%	+$40.8K	0.01%	484
2025 Q2	$220K	Sell	5,726 -1,338	-19%	-$51.1K	0.01%	522
2025 Q1	$274K	Sell	7,064 -4,206	-37%	-$154K	0.01%	434
2024 Q4	$381K	Sell	11,270 -11,070	-50%	-$399K	0.02%	369
2024 Q3	$913K	Sell	22,340 -3,335	-13%	-$136K	0.04%	256
2024 Q2	$988K	Buy	+25,675	New	+$1.08M	0.05%	239

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Daymark Wealth Partners's GSK Position: Q2 2026 in Review

Daymark Wealth Partners reduced its GSK (GSK) stake by 3% in Q2 2026, selling an estimated $14.2K and leaving 8,783 shares worth $460K. The position accounts for 0.01% of the portfolio, ranked #512.

Daymark Wealth Partners first reported a position in GSK in Q2 2024 and has held it in 9 quarters since. The position peaked at $988K in Q2 2024. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Daymark Wealth Partners held 8,783 shares of GSK worth $460K as of Q2 2026.
Daymark Wealth Partners sold 268 GSK shares in Q2 2026, an estimated $14.2K.
GSK made up 0.01% of Daymark Wealth Partners's portfolio in Q2 2026, its #512 holding.
Daymark Wealth Partners first reported a position in GSK in Q2 2024 and has held it in 9 quarters since.
Daymark Wealth Partners's GSK position peaked at $988K in Q2 2024.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.